Intranasal oestrogen cream for the prevention of epistaxis in patients with bleeding disorders

Haemophilia

Volumn 17, Issue 1, 2011, Pages 164-164

  Ross, C S ^a   Pruthi, R K ^a   Schmidt, K A ^a   Eckerman, A L ^a   Rodriguez, V ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR CONCENTRATE; CONJUGATED ESTROGEN; ESTROGEN;

ADOLESCENT; ADULT; BLEEDING DISORDER; CHILD; CLINICAL ARTICLE; CLINICAL PRACTICE; DISEASE ASSOCIATION; DRUG ABSORPTION; EPISTAXIS; FEMALE; GLANZMANN DISEASE; HUMAN; LETTER; MALE; PRESCRIPTION; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME; VON WILLEBRAND DISEASE;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; BLOOD COAGULATION DISORDERS; CHILD; EPISTAXIS; ESTROGENS; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79951875991     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2010.02356.x     Document Type: Letter

References (5)

1. Bergler W, Sadick H, Gotte K, Riedel F, Hormann K. Topical estrogens combined with argon plasma coagulation in the management of epistaxis in hereditary hemorrhagic telangiectasia. Ann Otol Rhinol Laryngol 2002; 111: 222-28.
2. Vase P. Estrogen treatment of hereditary hemorrhagic telangiectasia: a double-blind controlled clinical trial. Acta Med Scand 1981; 209: 393-96.
3. Harrison DF. Use of estrogen in treatment of familial hemorrhagic telangiectasia. Laryngoscope 1982; 92: 314-20.
4. Flessa HC, Glueck HI. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): management of epistaxis in nine patients using systemic hormone therapy. Arch Otolaryngol 1977; 103: 148-51.
5. Mehrizi A, Weber DR. Estrogen therapy for recurrent epistaxis: case histories and literature review. Hosp Pharm 1999; 34: 1057-64.